TY - JOUR
T1 - Acute encephalitis in immunocompetent adults
AU - Venkatesan, Arun
AU - Michael, Benedict D.
AU - Probasco, John C.
AU - Geocadin, Romergryko G.
AU - Solomon, Tom
N1 - Funding Information:
AV is supported by the National Institutes of Health and Maryland Stem Cell Research Fund. BDM is supported by grant funding from the Wellcome Trust, the Academy of Medical Science, the British Medical Association, and the National Institute for Health Research. TS is supported by the National Institute for Health Research, the National Institute for Health Research programme grant for applied research (number RP-PG-01081–0,048 ), and the European Union's Horizon 2020 research and innovation programme ZikaPLAN (grant agreement 734584 ).
Publisher Copyright:
© 2019 Elsevier Ltd
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2019/2/16
Y1 - 2019/2/16
N2 - Encephalitis is a condition of inflammation of the brain parenchyma, occurs as a result of infectious or autoimmune causes, and can lead to encephalopathy, seizures, focal neurological deficits, neurological disability, and death. Viral causes account for the largest proportion, but in the last decade there has been growing recognition of anti-neuronal antibody syndromes. This Seminar focuses on the diagnosis and management of acute encephalitis in adults. Although viral and autoimmune causes are highlighted because of their prominent roles in encephalitis, other infectious pathogens are also considered. The role of cerebrospinal fluid studies, MRI, and novel diagnostic modalities (eg, next-generation sequencing) are discussed. Management approaches, including treatment of acute neurological complications and the use of immune suppressive and modulatory drugs for cases of suspected or confirmed autoimmune cause, are covered. Additionally, we discuss the remaining challenges in the diagnosis, management, and prognosis of encephalitis.
AB - Encephalitis is a condition of inflammation of the brain parenchyma, occurs as a result of infectious or autoimmune causes, and can lead to encephalopathy, seizures, focal neurological deficits, neurological disability, and death. Viral causes account for the largest proportion, but in the last decade there has been growing recognition of anti-neuronal antibody syndromes. This Seminar focuses on the diagnosis and management of acute encephalitis in adults. Although viral and autoimmune causes are highlighted because of their prominent roles in encephalitis, other infectious pathogens are also considered. The role of cerebrospinal fluid studies, MRI, and novel diagnostic modalities (eg, next-generation sequencing) are discussed. Management approaches, including treatment of acute neurological complications and the use of immune suppressive and modulatory drugs for cases of suspected or confirmed autoimmune cause, are covered. Additionally, we discuss the remaining challenges in the diagnosis, management, and prognosis of encephalitis.
UR - http://www.scopus.com/inward/record.url?scp=85061388023&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061388023&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(18)32526-1
DO - 10.1016/S0140-6736(18)32526-1
M3 - Review article
C2 - 30782344
AN - SCOPUS:85061388023
SN - 0140-6736
VL - 393
SP - 702
EP - 716
JO - The Lancet
JF - The Lancet
IS - 10172
ER -